Search results for "VIH"

showing 10 items of 255 documents

Effects of activated carbon ageing in three PCB contaminated sediments: Sorption efficiency and secondary effects on Lumbriculus variegatus.

2015

The sorption efficiency and possible secondary effects of activated carbon (AC) (o 63-200 μm) was studied with Lumbriculus variegatus in three PCB contaminated sediments applying long AC-sediment contact time (3 years). AC amendment efficiently reduced PCB bioavailability as determined with both, L. variegatus bioaccumulation test and passive samplers. However, dose related secondary effects of AC on egestion rate and biomass were observed (applied doses 0.25% and 2.5% sediment dry weight). The sorption capacity and secondary effects remained similar when the experiments were repeated after three years of AC-sediment contact time. Further, transmission electron microscopy (TEM) samples reve…

Lumbriculus variegatusGeologic Sediments010504 meteorology & atmospheric sciencessedimentit010501 environmental sciences01 natural sciencestransmission electron microscopy (TEM)activated carbonPCBsWaste Management and Disposalta116Water Science and TechnologybiologyChemistryEcological ModelingReproductionSorptionPollutionPolychlorinated Biphenyls6. Clean watersediment remediationEnvironmental chemistryBioaccumulationCharcoalkunnostusmedicine.drugPCB-yhdisteetEnvironmental Engineeringta1172AmendmentelektronimikroskopiaBiological Availabilitycomplex mixturesDry weightMicroscopy Electron TransmissionmedicineAnimalsOligochaeta0105 earth and related environmental sciencesCivil and Structural EngineeringSedimentPDMS methodbiology.organism_classificationLipid MetabolismBioavailability13. Climate actionsaatavuusaktiivihiiliWater Pollutants ChemicalActivated carbonWater research
researchProduct

La estigmatización del VIH/SIDA: La respuesta desde el trabajo social

2018

El SIDA/VIH es la enfermedad de la inmunodeficiencia humana, siendo el VIH el virus (la- tente o no) y el SIDA el síndrome ya adquirido en la persona que destruye el sistema inmunológico, y que hace que no se tengan las suficientes defensas para poder combatir cualquier tipo de enfermedad. A pesar de que es una enfermedad conocida y extendida globalmente, la sociedad tiene un gran des- conocimiento sobre sus efectos y la población sigue excluyendo socialmente a las personas afectadas, asociando la enfermedad a colectivos lgtb (lesbianas, gays, transexuales, bisexuales). Esta investigación tiene como objeto normalizar la visión de la sociedad respecto a la enfermedad desde el papel del área …

Malalties transmissibles PrevencióVIH/SIDA Trabajo Social estigmatización social intervención social percepción.Treball socialSida36
researchProduct

Week 96 efficacy and safety results of the phase 3, randomized EMERALD trial to evaluate switching from boosted-protease inhibitors plus emtricitabin…

2019

Darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) 800/150/200/10 mg was investigated through 96 weeks in EMERALD (NCT02269917). Virologically-suppressed, HIV-1-positive treatment-experienced adults (previous non-darunavir virologic failure [VF] allowed) were randomized (2:1) to D/C/F/TAF or boosted protease inhibitor (PI) plus emtricitabine/tenofovir-disoproxil-fumarate (F/TDF) over 48 weeks. At week 52 participants in the boosted PI arm were offered switch to D/C/F/TAF (late-switch, 44 weeks D/C/F/TAF exposure). All participants were followed on D/C/F/TAF until week 96. Efficacy endpoints were percentage cumulative protocol-defined virologic rebound (PDVR; confirmed vira…

MaleDOLUTEGRAVIRSustained Virologic ResponseHIV InfectionsGastroenterologychemistry.chemical_compound0302 clinical medicineMedicine and Health SciencesEmtricitabine030212 general & internal medicinePharmacology & PharmacyDarunavir0303 health sciencesAlanineDrug SubstitutionCobicistatEmtricitabine Tenofovir Disoproxil Fumarate Drug CombinationLamivudineAntiretroviralsMiddle AgedViral LoadOPEN-LABEL3. Good healthWEIGHT-GAINDrug CombinationsTreatment OutcomeDolutegravirNON-INFERIORITYFemaleSafetyViral loadLife Sciences & Biomedicinemedicine.drugTabletsAdultmedicine.medical_specialtyEfficacyAnti-HIV AgentsRITONAVIREmtricitabineTENOFOVIR ALAFENAMIDELAMIVUDINETenofovir alafenamideSingle-tablet regimen03 medical and health sciencesInternal medicineVirologymedicineVIH (Virus)HumansSwitch studyProtease InhibitorsTenofovirDarunavirAgedPharmacologyScience & Technology030306 microbiologybusiness.industryHIV (Viruses)AdenineDarunavir/cobicistat/emtricitabine/TAFAntiretroviral agentsCOBICISTATMAINTENANCEchemistry[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologieHIV-1RitonavirCobicistat[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologiebusinessRESISTANCE
researchProduct

Associations of Leisure-Time Physical Activity Trajectories with Fruit and Vegetable Consumption from Childhood to Adulthood: The Cardiovascular Risk…

2019

A physically active lifestyle and a diet rich in vegetables and fruits have a central role in promoting health. This study examined the associations between leisure-time physical activity (LTPA) trajectories and fruit and vegetable consumption (FVC) from childhood to middle age. The data were drawn from the Cardiovascular Risk in Young Finns Study with six age cohorts. Participants were 9 to 18 years (n = 3536

MaleHealth Toxicology and MutagenesisLeisure timephysical activityliikuntaruokavaliotCardiovascular SystemVARIABLES0302 clinical medicineRisk FactorsVegetablesMedicine030212 general & internal medicineChildkohorttitutkimusDIETARY-CHANGESFinland18 COUNTRIESvihanneksetAge cohortsNaisten- ja lastentaudit - Gynaecology and paediatricsMiddle Aged3142 Public health care science environmental and occupational healthCardiovascular DiseasesOBESITYtrajectory1181 Ecology evolutionary biologyFOOD-FREQUENCY QUESTIONNAIREFemaleHEALTH BEHAVIOR-CHANGEfyysinen aktiivisuusAdultadulthoodAdolescentlongitudinalKansanterveystiede ympäristö ja työterveys - Public health care science environmental and occupational healthPhysical activity030209 endocrinology & metabolismpitkittäistutkimusMotor ActivityArticle03 medical and health sciencesFEV1/FVC ratioAGELeisure ActivitiesHumansVALIDITYExerciseLife Style1172 Environmental scienceschildhoodConsumption (economics)business.industryPublic Health Environmental and Occupational HealthMiddle ageDietFruitadolescenceGENDERSelf ReportSedentary BehaviorbusinessdietDemographyhedelmätInternational journal of environmental research and public health
researchProduct

Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe

2016

Transmitted human immunodeficiency virus drug resistance in Europe is stable at around 8%. The impact of baseline mutation patterns on susceptibility to antiretroviral drugs should be addressed using clinical guidelines. The impact on baseline susceptibility is largest for nonnucleoside reverse transcriptase inhibitors.

MaleHuman immunodeficiency virus 1EtravirineRNA directed DNA polymerase inhibitordarunavirHIV InfectionsSettore MED/42 - Igiene Generale E Applicata:Disciplines and Occupations::Health Occupations::Medicine::Public Health [Medical Subject Headings]:Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings]Salud públicageneticsInhibidores de proteasas:Analytical Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Data Collection::Vital Statistics::Morbidity::Prevalence [Medical Subject Headings]atazanavirmedia_commontransmission:Geographicals::Geographic Locations::Europe [Medical Subject Headings]3. Good healthmicrobial sensitivity testpriority journalEurope ; HIV-1 ; antiretroviral therapy ; drug resistance ; transmissionHIV/AIDSlamivudineReverse Transcriptase Inhibitors/pharmacologyanti human immunodeficiency virus agentDrugMicrobiology (medical)medicine.medical_specialtyantiviral susceptibility:Phenomena and Processes::Genetic Phenomena::Genetic Variation::Mutation [Medical Subject Headings]media_common.quotation_subjectantiretroviral therapy030106 microbiologyHIV Infections/drug therapy:Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Anti-Infective Agents::Antiviral Agents::Anti-Retroviral Agents::Reverse Transcriptase Inhibitors [Medical Subject Headings]Microbial Sensitivity TestsRILPIVIRINEArticleEFAVIRENZ03 medical and health sciencestransmitted drug resistanceSDG 3 - Good Health and Well-beingHumansTransmissionhuman:Phenomena and Processes::Physiological Phenomena::Pharmacological Phenomena::Drug Resistance [Medical Subject Headings]REVERSE-TRANSCRIPTASE INHIBITORSRilpivirinaINTEGRASEMUTATIONSabacavirmajor clinical studyVirologyInfecciones por VIHRegimenAntiretroviral therapy; Drug resistance; Europe; HIV-1; Transmission; Medicine (all); Microbiology (medical); Infectious DiseaseschemistryDrug resistance:Chemicals and Drugs::Heterocyclic Compounds::Heterocyclic Compounds 1-Ring::Oxazines::Benzoxazines [Medical Subject Headings]MutationHIV-10301 basic medicinenevirapineDrug resistanceCommunicable diseases:Analytical Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Statistics as Topic::Confidence Intervals [Medical Subject Headings]chemistry.chemical_compoundantiviral therapyINFECTIONMedicine and Health SciencesPrevalence:Analytical Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Data Collection::Surveys and Questionnaires [Medical Subject Headings]ViralNon-U.S. Gov'tReverse-transcriptase inhibitorantiretrovirus agentResearch Support Non-U.S. Gov'tMedicine (all)Human immunodeficiency virus infected patientMiddle AgedvirologyPREVALENCEAntiretroviral therapyEncuestas y CuestionariosANTIRETROVIRAL TREATMENTEuropeInfectious DiseasesHIV-1/drug effectsHIV Protease Inhibitors/pharmacologyRilpivirineReverse Transcriptase Inhibitors:Diseases::Immune System Diseases::Immunologic Deficiency Syndromes::HIV Infections [Medical Subject Headings]FemaleHIV drug resistancemedicine.drugAdultHuman immunodeficiency virus proteinase inhibitor:Chemicals and Drugs::Organic Chemicals::Nitriles::Rilpivirine [Medical Subject Headings]EfavirenzAnti-HIV AgentsResearch SupportResistencia a medicamentosSettore MED/17 - MALATTIE INFETTIVEantiviral resistanceInternal medicineAnti-HIV Agents/pharmacologyDrug Resistance ViralJournal Articlemedicine:Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Molecular Mechanisms of Pharmacological Action::Enzyme Inhibitors::Protease Inhibitors [Medical Subject Headings]abacavir plus lamivudineEuropa (Continente)Antiretroviral therapy; Drug resistance; Europe; HIV-1; Transmission; Adult; Anti-HIV Agents; Drug Resistance Viral; Europe; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Prevalence; Reverse Transcriptase Inhibitors; Microbiology (medical); Infectious DiseasesemtricitabinenonhumanIntervalos de confianzadrug resistanceMutaciónAntiretroviral therapy; Drug resistance; Europe; HIV-1; Transmissionbusiness.industryHIVpredictionInhibidores de la transcriptasa inversaHIV Protease InhibitorsHuman immunodeficiency virus 1 infectiontenofovirINDIVIDUALSDrug Resistance Viral/geneticsBenzoxazinasETRAVIRINEdrug effects3121 General medicine internal medicine and other clinical medicinePrevalenciabusiness
researchProduct

Effectiveness, safety/tolerability of OBV/PTV/r ± DSV in patients with HCV genotype 1 or 4 with/without HIV-1 co-infection, chronic kidney disease (C…

2019

Background and aims Limited data are available on the effectiveness and tolerability of direct-acting antivirals (DAAs) therapies in the real world for HCV-infected patients with comorbidities. This study aimed to describe the effectiveness of OBV/PTV/r +/- DSV (3D/2D regimen) with or without ribavirin (RBV) in HCV or HCV/HIV co-infected patients with GT1/GT4 and CKD (IIIb-V stages), including those under hemodialysis and peritoneal dialysis in routine clinical practice in Spain in 2015. Material and methods Non-interventional, retrospective, multicenter data collection study in 31 Spanish sites. Socio-demographic, clinical variables, study treatment characteristics, effectiveness and toler…

Malemedicine.medical_treatmentHIV InfectionsHepacivirus0302 clinical medicine:Infections::Virus Diseases::Hepatitis Viral Human::Hepatitis C::Hepatitis C Chronic [DISEASES]ribavirina2-Naphthylaminemediana edad:virosis::infecciones por virus ARN::infecciones por Retroviridae::infecciones por Lentivirus::infecciones por VIH [ENFERMEDADES]ancianoSulfonamidesCoinfectionfarmacoterapiaLiver Diseasesvirus diseasesValineInfeccions per VIH - TractamentCirrhosisNephrology/drug therapyMedicine030211 gastroenterology & hepatologyDrug Therapy Combinationinsuficiencia renalmedicine.medical_specialty:virosis::hepatitis viral humana::hepatitis C::hepatitis C crónica [ENFERMEDADES]GenotypeProlineSciencecompuestos macrocíclicosSurgical and Invasive Medical ProceduresGastroenterology and HepatologyAntiviral AgentsMicrobiologyUrinary System ProceduresPeritoneal dialysis03 medical and health sciencesDrug TherapyHumansLost to follow-upRenal Insufficiency ChronicUracilAgedRetrospective StudiesFlavivirusesanilidasOrganismsOrgan Transplantationmedicine.diseasedigestive system diseasesRegimenchemistryHIV-1Malalties del ronyóCarbamatesgenotipoCyclopropanesRNA virusesantivíricosSustained Virologic ResponsePhysiologyhumanoschemistry.chemical_compoundChronic Kidney DiseaseMedicine and Health SciencesRenal TransplantationAnilidesRenal Insufficiency030212 general & internal medicinePathology and laboratory medicinecoinfecciónMultidisciplinaryKidney diseasesHepatitis C virus:Infections::Infections::Virus Diseases::RNA Virus Infections::Retroviridae Infections::Lentivirus Infections::Infections::Virus Diseases::HIV Infections [DISEASES]resultado del tratamientoQR:Infections::Coinfection [DISEASES]Middle AgedMedical microbiologyHepatitis CTreatment OutcomeInfectious DiseasesTolerabilityResearch DesigncarbamatosVirusesFemaleHemodialysisPathogensVIH-1Research ArticleGlomerular Filtration RateMacrocyclic CompoundsClinical Research DesignLactams MacrocyclicResearch and Analysis MethodssulfonamidasRenal DialysisInternal medicineRibavirinMedical DialysismedicineDialysisTransplantationRenal Physiology/tratamiento farmacológicoRitonavirBiology and life sciencesbusiness.industryRibavirinestudios retrospectivosViral pathogensHepatitis C ChronicHepatitis virusesMicrobial pathogens:enfermedades parasitarias::coinfección [ENFERMEDADES]Spaindiálisis renalCo-InfectionsPhysical therapyinfecciones por VIHAdverse EventsbusinessHepatitis C - TractamenturaciloKidney diseasePLoS ONE
researchProduct

Advancements in Sustainable PVDF Copolymer Membrane Preparation Using Rhodiasolv® PolarClean As an Alternative Eco-Friendly Solvent

2021

In this work, Rhodiasolv® PolarClean was employed as a more sustainable solvent for the preparation of poly(vinylidene fluoride-hexafluoropropylene) (PVDF-HFP) flat sheet membranes via phase inversion technique by coupling vapour induced phase separation (VIPS) and non-solvent induced phase separation (NIPS) processes. Preliminary calculations based on Hansen solubility parameters well predicted the solubilization of the polymer in the selected solvent. The effect of exposure time on humidity and the influence of polyethylene glycol (PEG), polyvinyl pyrrolidone (PVP) and sulfonated polyether sulfone (S-PES) on membrane properties and performance, were evaluated. Three different coagulation …

Materials scienceMicrofiltrationUltrafiltrationEnvironmental engineeringPolyethylene glycolPVDF-HFP membrane preparationEnvironmental technology. Sanitary engineeringchemistry.chemical_compoundvihreä kemiaPolarCleanPhase inversion (chemistry)green solventsTD1-1066chemistry.chemical_classificationkalvot (tekniikka)General EngineeringmuovitekniikkaPolymerpolymeerikemiaTA170-171SolventHildebrand solubility parameterMembranechemistryChemical engineeringliuottimet
researchProduct

Study of the intestinal microbiota in the HIV infection and the effect of a nutritional intervention

2017

Introducción Desde la aplicación de la Terapia Antirretroviral de Gran Actividad (TARGA) la supervivencia de los sujetos infectados con el virus de la inmunodeficiencia humana (VIH) se ha incrementado considerablemente; sin embargo, su expectativa de vida es todavía 10 años menor a la de la media de la población. Esta reducción es debida a enfermedades no relacionadas con el síndrome de inmunodeficiencia adquirida (SIDA). Entre las principales causantes de este descenso se encuentra el aumento de la incidencia de problemas cardiovasculares. Recientemente, se ha descrito que la activación inmune persistente y la inflamación crónica son dos factores implicados en la morbimortalidad de estos p…

MetagenómicaDisbiosisVIHRedes ecológicas y funcionales
researchProduct

The emission reduction potential of electric transport modes in Finland

2021

The transportation sector has become the fastest growing source of greenhouse gas (GHG) emissions. One solution to mitigate the impacts is a shift towards electric modes. Where previous studies have only focused on the replacement of individual modes, our study presents a more holistic approach by comparing land-based, water-based and airborne transportation modes. We study the GHG emission reduction potentials of electric cars, buses, trains, ferries and aircraft in comparison to existing modes on 34 routes within Finland and across the Baltic Sea to Sweden and Estonia. By comparing the GHG emissions in carbon dioxide equivalents (CO2-eq) per passenger kilometer for each mode, we also cons…

Modal shiftraideliikennematka-aika/dk/atira/pure/sustainabledevelopmentgoals/affordable_and_clean_energylaivaliikenneElectric aviationtieliikenneElectric transport modeslentoliikennekasvihuonekaasutSDG 3 - Good Health and Well-beingtravel timeGreenhouse gas emissions/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingsähköajoneuvotpäästötSDG 7 - Affordable and Clean Energy
researchProduct

Activated Cashew Carbon-Manganese Oxide Based Electrodes for Supercapacitor Applications

2023

The current global energy challenge which affects most developing countries in particular, is of major source of concern today. The availability of less expensive techniques of storing excess generated energy is critical to the success of the renewable energy roadmaps implementation. In this study, hydrothermal and chemical leaching methods have been used to synthesize MnO2 nanoparticles using KMnO4 and MnSO4 as precursors at 140 °C and from natural local manganese ore. Activated Carbon (ACF) have also been produced from agricultural Cashew biomass waste, through a physical carbonization and KOH activation process using temperatures of 700 °C – 900 °C for periods between 1-2 hours. The as-p…

Multidisciplinaryelectrochemistrymaatalousjätteetaktiivihiilisuperkondensaattoritelektroditactivated carboncharacterizationsupercapacitorbiomassa (teollisuus)agrowastesähkökemia
researchProduct